Free Republic 2nd Quarter Fundraising Target: $85,000 Receipts & Pledges to-date: $21,784
25%  
Woo hoo!! And the first 25% is in!! Thank you all very much!!

Keyword: merck

Brevity: Headers | « Text »
  • Special Report: Lost hooves, dead cattle before Merck halted Zilmax sales

    01/01/2014 5:56:02 PM PST · by fella · 69 replies
    Reuters ^ | 30 Dec 2013 | By P.J. Huffstutter and Tom Polansek
    (Reuters) - The U.S. beef industry's dependence on the muscle-building drug Zilmax began unraveling here, on a sweltering summer day, in the dusty cattle pens outside a Tyson Foods Inc slaughterhouse in southeastern Washington state. As cattle trailers that had traveled up to four hours in 95-degree heat began to unload, 15 heifers and steers hobbled down the ramps on August 5, barely able to walk. The reason: The animals had lost their hooves, according to U.S. Department of Agriculture documents reviewed by Reuters. The documents show the 15 animals were destroyed. The next day, the hottest day of the...
  • Merck files notice of 500 Montco layoffs

    11/05/2013 12:33:48 PM PST · by Phillyred · 15 replies
    Philly.com ^ | November 2, 2013 | DAVID SELL
    The drugmaker Merck & Co. will lay off 500 people from its facility in West Point, Montgomery County, between Dec. 23 and Jan. 5. Merck said on Oct. 1 that it would eliminate 8,500 jobs from its worldwide workforce beyond the 7,500 it had not yet cut from an earlier restructuring plan, but company officials were not specific about where and when. Several big pharmaceutical companies with operations in the area are cutting jobs. Message boards devoted to Merck have been full of discussions about which units would lose people, but official public notice of the 500 job cuts at...
  • Merck to cut costs by $2.5 billion, eliminate 8,500 jobs

    10/01/2013 6:30:03 AM PDT · by RoosterRedux · 26 replies
    reuters.com ^ | 10/1/2013
    Merck & Co (MRK.N), taking a cue from other drugmakers that have slashed research spending to bolster earnings, on Tuesday said it plans to cut annual operating costs by $2.5 billion by the end of 2015 and eliminate 8,500 jobs. By slimming down, Merck aims to narrow its focus to products with the best chance of winning regulatory approval and achieving substantial sales, while jettisoning research products with less likelihood of success. The planned job cuts, representing more than 10 percent of the company's global workforce of 81,000 employees, would be in addition to previously announced cuts of 7,500 positions.
  • Look which companies dumping Boy Scouts

    02/05/2013 10:50:39 AM PST · by Maelstorm · 81 replies
    http://www.wnd.com ^ | 2-5-2013 | Art Moore
    Major corporations that have donated to the Boy Scouts of America in recent years are largely remaining quiet ahead of the highly anticipated vote Wednesday on the organization’s policy on homosexuals, but some have made it clear their money will go only to groups that don’t discriminate on the basis of sexual orientation. In 2010, the latest year for which figures are available, the top donors to the Scouts, listed in descending order according to amount, were Intel, Emerson, Verizon, 3M, Bank of America, Wells Fargo, Pfizer, Valero, UPS, U.S. Bank, Eli Lilly and Co., GE, Monsanto, Medtronic, PNC, Nationwide,...
  • Boy Scouts of America: Merck pulls funding in protest at gay ban

    12/10/2012 6:22:04 PM PST · by DeaconBenjamin · 27 replies
    guardian.co.uk, ^ | Monday 10 December 2012 11.51 EST | Dominic Rushe
    The drugs giant Merck has suspended its funding for the Boy Scouts of America, citing its discrimination against gay people. The maker of top-selling drugs including asthma treatment Singulair and the HPV vaccine Gardasil joins Intel and UPS. In July the BSA reaffirmed its long-time policy barring openly gay members from joining the organisation and barring gay and lesbian scout leaders. The ban sparked a national backlash and was condemned by both president Barack Obama and his Republican presidential challenger Mitt Romney. Scouts for Equality has petitioned all major sponsors in an attempt to get the BSA to overturn the...
  • Merck Hid Evidence Of Vioxx Harm: Study

    07/10/2012 11:08:30 AM PDT · by To-Whose-Benefit? · 9 replies
    Pharmalot ^ | July 10, 2012 | Ed Silverman
    And so, the Vioxx saga continues. Nearly eight years after Merck withdrew the controversial painkiller over links to heart attacks and strokes, a new paper indicates the drugmaker hid evidence that Vioxx tripled the risk of cardiovascular death for more than three years before taking the pill off the market in 2004. During the same period, the paper in the American Heart Journal notes, Merck had regularly insisted such an increased [risk] did not exist.
  • Merck vaccine fraud exposed by two Merck virologists [title truncated]

    06/28/2012 4:38:10 AM PDT · by My hearts in London - Everett · 20 replies
    NaturalNews.com ^ | June 28, 2012 | Mike Adams
    Breaking news: According to two Merck scientists who filed a False Claims Act complaint in 2010 -- a complaint which has just now been unsealed -- vaccine manufacturer Merck knowingly falsified its mumps vaccine test data, spiked blood samples with animal antibodies, sold a vaccine that actually promoted mumps and measles outbreaks, and ripped off governments and consumers who bought the vaccine thinking it was "95% effective." See that False Claims Act document at: www.naturalnews.com/gallery/documents/Merck-False-Claims-Act.pdf According to Stephen Krahling and Joan Wlochowski, both former Merck virologists, the Merck company engaged in all the following behavior: • Merck knowingly falsified its...
  • Va. Supreme Court rules in Merck class action

    03/07/2012 6:51:17 AM PST · by Miami Vice · 5 replies
    Legal Newsline ^ | 3-7-12 | MichaelP. Tremoglie
    The Virginia Supreme Court has issued a ruling in the case of Casey v. Merck & Co. The United States Court of Appeals for the Second Circuit had asked the Virginia court to rule on two issues regarding Virginia law and a statute of limitations for class actions. A class action was filed ...
  • Feds contine to ignore mounting Gardasil bodycount

    12/22/2011 5:35:47 AM PST · by markomalley · 162 replies · 1+ views
    Washington Examiner ^ | 10/19/11 | Barbara Hollingsworth
    It was too late for 21-year-old Christina Tarsell and 17-year-old Jessica Ericzon. Both healthy, athletic young women suddenly dropped dead shortly after receiving their final injection of Gardasil, a vaccine developed by Merck to protect girls and young women from cervical cancer caused by the human papilloma virus (HPV). But when Christina’s and Jessica’s shocked families tried to get the Food and Drug Administration (FDA) to investigate a vaccine it had inexplicably fast-tracked through the approval process even though only one percent of all cancer deaths are due to cervical cancer, they hit a brick wall. The Tarsells and Ericzons...
  • Sandusky Scandal: Kenneth Frazier a serious conflict of interest (Free Republic exclusive)

    11/13/2011 12:05:38 PM PST · by OutSpot · 78 replies
    Outspot | 13 Sept. 20011 | Outspot
    In the ongoing saga of Penn State University failures and misguided moral compass, there is unfortunately one more insult to injury to the Sandusky child rape victims and their families. Penn State’s board of trustees last Friday appointed Kenneth Frazier, the chief executive of Merck & Co. as well as Penn State alumni, to lead a special committee to investigate the Sandusky sordid matter. As a Penn State alum myself, it turns my stomach knowing that Mr. Frazier volunteered himself and has serious conflicts of interest in the scandal. Anyone is able to review the Annual reports of Sandusky’s “Second...
  • CDC Has Just Recommended Routine HPV Vaccinations for Boys!

    In a shocking move, the Centers for Disease Control and Prevention said today that the HPV vaccine Gardasil should be given to 11- to 12-year-old boys as well as girls. The CDC’s Advisory Committee on Immunization Practices unanimously recommended routine vaccinations for boys to protect them from cancers related to the human papillomavirus, or HPV. Federal health officials usually adopt what the panel says and asks doctors and patients to follow the recommendations. Merck & Co. designed Gardasil to prevent sexually transmitted HPV infections, which can lead to genital warts and cervical cancer in women, and cancer of the penis...
  • BREAKING: CDC Backs HPV Vaccine for Boys

    10/25/2011 12:58:48 PM PDT · by Scythian · 193 replies
    A Centers for Disease Control and Prevention advisory panel recommended Tuesday routine vaccination of boys ages 11 and 12 with Gardasil, which protects against infection from human papilloma virus. The panel unanimously approved the plan, with 13 votes in favor and one abstention. The panel also advised that vaccinations with Gardasil begin in boys as young as 9 years old. The recommendation, from the Advisory Committee on Immunization Practices, elevates the urgency placed on immunization against HPV, one of the most common sexually-transmitted diseases and a major cause of cervical cancer. Previously, doctors were free to use the vaccine in...
  • CDC now calling U.S. households and demanding child immunization records

    09/29/2011 4:46:18 AM PDT · by Scythian · 86 replies
    (NaturalNews) The U.S. Centers for Disease Control, which has been comprehensively exposed as a vaccine propaganda organization promoting the interests of drug companies, is now engaged in a household surveillance program that involves calling U.S. households and intimidating parents into producing child immunization records. As part of what it deems a National Immunization Survey (NIS), the CDC is sending letters to U.S. households, alerting them that they will be called by "NORC at the University of Chicago" and that households should "have your child's immunization records handy when answering our questions." (See copies of the letter, below.) This NIS vaccine...
  • Rumors, untruths find a friend in Michele Bachmann

    09/18/2011 11:09:55 AM PDT · by Cincinatus' Wife · 74 replies
    It's one thing to have a philosophical disagreement with the Texas governor on whether he should have mandated a vaccine for girls against a sexually transmitted virus. But it's an entirely different matter to spread false rumors about the vaccine, hoping to leverage parental fears for political gain. That's the depths to which Minnesota's Michele Bachmann has sunk in her bid to counter Rick Perry's surge in polls. It's conduct unbecoming a member of Congress, much less a candidate for the Republican presidential nomination. Bachmann used the issue last week at the CNN/Tea Party Express debate in Tampa to land...
  • Bachmann Took Money from GlaxoSmithKline — Manufacturer of HPV Vaccine (Competitor of Merck)

    09/17/2011 10:18:28 AM PDT · by xzins · 240 replies
    The American Pundit ^ | 16 Sep 11 | Stephen Tawney
    good times good times. Meanwhile, Bachman has taken somewhere north of $140,000 from pharmaceutical companies. Those donors include Abbott Labs, Pfizer, GlaxoSmithKline, AstraZeneca, Novartis, Eli Lilly and Bayer. Yet, not a dollar of all that pharma money, from such a wide range of the world’s largest drugmakers, came from Merck. Might Bachmann be going after Merck on behalf of that company’s competitors who also happen to be Bachmann donors? She’s claiming a vaccine manufactured by Merck (Gardisil) causes mental retardation. Meanwhile, she’s taking campaign donations from Merck’s top HPV vaccine (Cervarix) competitor, GlaxoSmithKline.Hey, that’s not at all suspicious.Weren’t we...
  • Professors offer more than $10,000 for proof that Bachmann’s story about HPV is true

    09/15/2011 8:21:13 AM PDT · by indianrightwinger · 49 replies
    Yahoo News ^ | Chris Moody
    Professors offer more than $10,000 for proof that Bachmann’s story about HPV is true By Chris Moody Political Reporter Minnesota Rep. Michele Bachmann's story about a woman who claimed that her daughter suffered "mental retardation" after receiving a vaccine against HPV could fetch the woman's family thousands of dollars. But the family can only collect if Bachmann or the unnamed woman can prove the story is true. Two bioethics professors have offered to pay more than $10,000 for medical records that prove the anecdote Bachmann told after Monday night's Republican presidential debate is true, the Minneapolis Star Tribune reports: Steven...
  • The right and wrong way to talk about Gardasil; Update: A really, really stupid attack on Palin

    09/13/2011 2:33:50 PM PDT · by rintense · 20 replies · 1+ views
    Michelle Malkin ^ | 09/13/11 | Michelle Malkin
    It’s a freakingly obvious night and day difference — Perry’s MANDATE on families and the MANDATE on insurers going over the heads of the state legislature versus the Palin administration’s decision to accept federal subsidies to increase access to those who choose to take it. (Note: Gardasil is not and never has been mandated in the state of Alaska.) Preston also objects to indirect costs imposed by the Palin administration’s program on taxpayers outside the state. Newsflash: The Perry executive order would have ordered Texas health officials to use federal Medicaid funding to cover the vaccine for young women —...
  • Perry understates Merck’s campaign donations around HPV vaccine order

    09/13/2011 1:32:15 PM PDT · by TLI · 51 replies
    The Washington Independant ^ | 09.13.11 | Mary Tuma
    During Monday night’s CNN/Tea Party GOP debate, Republican presidential contender Michele Bachmann took aim at Gov. Rick Perry’s 2007 executive order requiring middle school girls to be vaccinated against the human papilloma virus (HPV), the most frequent sexually transmitted disease and a leading cause of cervical cancer. Bachmann called out Perry’s financial ties to Merck & Co., the manufacturer of the vaccine, Gardasil — a group, she said, that stood to gain from the order. Bachmann insinuated the governor’s decision may have been swayed by the company’s donations to his campaign. “We cannot forget that in the midst of this...
  • Merck to Cut 16,000 Workers as Drugmaker Closes 16 Plants, Labs

    07/08/2010 11:33:52 PM PDT · by My Favorite Headache · 29 replies
    Daily Finance ^ | 7-9-2010
    Merck (MRK), the world's second largest drugmaker, said Thursday it plans to close eight manufacturing plants and eight research facilities around the world in its bid to save $3.5 billion a year. The Whitehouse Station, N.J.-based company is also reducing its workforce by 15%, or some 16,000 jobs, it said. The actions are part of a restructuring the company has undertaken following its $41 billion acquisition of rival Schering-Plough in November. In addition to the plant closings, Merck said it will consolidate some offices worldwide, as part of the restructuring begun last December. "Today's announcement is another important step as...
  • Former head of CDC lands lucrative job as president of Merck vaccine division, opinion

    12/23/2009 2:14:36 PM PST · by opentalk · 9 replies · 666+ views
    natural news ^ | December 22, 2009 | Mike Adams,
    You've heard it before, how the pharmaceutical industry has a giant "revolving door" through which corporations and government agencies frequently exchange key employees. That reality was driven home in a huge way today when news broke that Dr. Julie Gerberding, who headed the CDC from 2002 through 2009, landed a top job with Merck, one of the largest drug companies in the world. Her job there? She's the new president of the vaccine division. How convenient. That means the former head of the CDC was very likely cultivating a relationship with Merck all these years, and now comes the big...
  • Merck Researcher Admits: Gardasil Guards Against Almost Nothing

    10/21/2009 5:44:00 AM PDT · by NYer · 58 replies · 1,689+ views
    CE ^ | October 21, 2009 | Steven W. Mosher
    [with Joan Robinson, Assistant Editor at the Population Research Institute]On the morning of 2 October 2009, one of us (Joan) joined an audience of mostly health professionals and listened as Dr. Diane Harper, the leading international developer of the HPV vaccines, gave a sales pitch for Gardasil. Gardasil, as you may know, is the new vaccine that is supposed to confer protection against four strains of the sexually transmitted Human Papillomavirus (HPV).Dr. Harper came to the 4th International Public Conference on Vaccination to prove to us the real benefits of Gardasil. Sadly, her own presentation left me (Joan) and others...
  • HPV Vaccine - What Parents Need to Know

    08/26/2009 5:11:05 AM PDT · by Kaslin · 103 replies · 2,363+ views
    Townhall.com ^ | August 25, 2009 | Janice Shaw Crouse
    I sat at a picnic table listening to various mothers discussing their hectic schedules trying to keep up with teenage daughters, all on the same sports team. When one mother told of squeezing in an appointment that morning to get her daughter the HPV shot that her doctor recommended, the conversation turned to the necessity to "protect" their girls in such troubling times. I stayed quiet, hoping to learn the values guiding these parents' decisions. Predictably, they had not thought through the issues, nor did they know the facts. Those mothers were merely following doctors' recommendations and that of all...
  • US to spend another $1 billion for flu vaccine

    07/12/2009 2:13:15 PM PDT · by Selene · 72 replies · 2,365+ views
    Reuters ^ | 7/12/2009
    WASHINGTON, July 12 (Reuters) - The United States will spend an another $1 billion for ingredients for an H1N1 vaccination, U.S. Health and Human Services Secretary Kathleen Sebelius said on Sunday. "There'll be another $1 billion worth of orders placed to get the bulk ingredients for an H1N1 vaccination. Congress has agreed with the president that this is the number one priority, keeping Americans safe and secure," Sebelius said on CNN. Sebelius has said plans were on track for a mid-October vaccination program, although it was not certain Americans would be offered the vaccine for the so-called swine flu.
  • Merck buying Schering-Plough in a $41.1B deal

    03/09/2009 6:24:39 AM PDT · by BenLurkin · 3 replies · 238+ views
    AP ^ | Monday March 9, 2009, 9:18 am EDT | Linda A. Johnson,
    Merck & Co. is buying Schering-Plough Corp. for $41.1 billion in stock and cash in a deal that gives the companies more firepower to compete in a drug industry facing slumping sales, tough generic competition and intense pricing pressures. The deal announced Monday would unite the maker of asthma drug Singulair with the maker of allergy medicine Nasonex and form the world's second-largest prescription drugmaker. Merck and Schering are already partners in a pair of popular cholesterol fighters, Vytorin and Zetia. The latest combination comes only a few weeks after Pfizer Inc. announced it has agreed to pay $68 billion...
  • Merck Seeks FDA Approval for Gardasil in Boys

    01/06/2009 1:40:49 PM PST · by BGHater · 12 replies · 738+ views
    WSJ ^ | 05 Jan 2009 | Jonathan D. Rockoff
    Merck is asking federal regulators to expand the use of its human papillomavirus vaccine to boys and young men.The company has asked the FDA to approve the Gardasil vaccine’s use in males ages 9 to 26 years to prevent genital warts and other lesions, CNBC’s Mike Huckman reported. In 2006, the FDA approved giving the vaccine to girls and women of those ages. We talked with a Merck spokeswoman who pointed to studies showing Gardasil’s effectiveness in young males.But the request will likely renew questions about Gardasil’s cost-effectiveness, especially with a price tag of $360 for a three-dose regimen. In...
  • Merck Focusing on Combination Vaccine (Attn: doctors, parents, no moral alternatives)

    12/31/2008 6:56:29 PM PST · by Sun · 33 replies · 1,075+ views
    cogforlife.org ^ | 12/24/2008 | David Mitchell
    Note: Merck's separate dose for rubella, Meruvax, uses aborted fetal cell lines and taints the entire MMR II vaccine. The separate doses of Attenuvax (measles) and Mumpsvax (mumps) use chick embryo. Without these separate doses for measles and mumps, there will be no moral alternative for parents! See contact information for Merck below. snip Merck Focusing on Combination Vaccine Manufacturer Stops Sales of Monovalents for Measles, Mumps, Rubella By David Mitchell 12/24/2008 Merck & Co. Inc. has stopped production and sales of its monovalent vaccines for measles, mumps and rubella. The manufacturer instead plans to focus on its combination vaccine,...
  • Merck Stops Producing Vaccines Not Based on Abortion

    12/31/2008 1:35:57 PM PST · by julieee · 36 replies · 1,150+ views
    LifeNews.com ^ | December 31, 2008 | Steven Ertelt
    Washington, DC -- A leading pro-life group that educates about the vaccines that are based on the cells from babies killed in abortions is worried about a new decision from the pharmaceutical giant Merck. The company has decided to stop producing some vaccines that are not made based on fetal cells from abortions.
  • Erin Brockovich: Gardasil (the case against Merck's HPV vaccine)

    08/07/2008 7:13:47 AM PDT · by weegee · 170 replies · 1,847+ views
    The Brockovich Report ^ | August 6, 2008 | Erin Brockovich
    We have been spending our days getting all our ducks armed for bear and in a row--all of our anti-Gardasil ducks, that is. From checking my various areas on the internet, to finding moderators to listening to the tragic and painful stories of victims of the Gardasil vaccine, it has been a very busy time for me and my team. Gardasil, as you should know by now, is an HPV vaccine sold by Merc, a vaccine with a flawed marketing campaign targeting young girls. The premise is that the vaccine will protect young girls from cervical cancer, as well as...
  • Merck Caught in Massive Scientific Fraud

    04/25/2008 9:48:25 AM PDT · by djf · 26 replies · 118+ views
    NaturalNews ^ | Mike Adams
    Drug giant Merck has been caught red-handed in a scheme to deceive the FDA and the public over the integrity of its scientific studies, say top medical authorities. According to reports that were (amazingly!) published in the Journal of the American Medical Association and detailed in the Washington Post, Merck waged a "campaign of deception" to disguise its in-house study authors as independent scientists working for universities. This scheme made the studies appear independent and unbiased, allowing them to carry more apparent credibility to FDA officials, doctors and other scientists. This fraud was conducted to boost the apparent scientific credibility...
  • Merck, Schering-Plough Sink on Vytorin

    03/31/2008 1:16:40 PM PDT · by BenLurkin · 7 replies · 356+ views
    AP Business ^ | Monday March 31, 3:55 pm ET | Damian Troise,
    NEW YORK (AP) -- Shares of Merck & Co. and Schering-Plough Corp. fell to record lows Monday, as analysts warned new clinical data would cause sales of their blockbuster cholesterol drug Vytorin to fall further. The companies market Vytorin through a joint venture, but earlier this year, partial results from a clinical study showed that it was no more effective at limiting plaque buildup than Merck's Zocor, a drug that is already available in generic form. Full results of that study were released Sunday. Vytorin is a combination of Zocor and Schering-Plough's drug Zetia. Schering-Plough shares plunged as low as...
  • FDA probing suicide risks from asthma drug

    03/27/2008 12:51:29 PM PDT · by metmom · 19 replies · 851+ views
    MSNBC.Com ^ | Thursday, March 27, 2008 | Associated Press
    WASHINGTON - The Food and Drug Administration said Thursday it is investigating a possible link between Merck’s best-selling asthma drug, Singulair, and suicide. FDA said it is reviewing reports of mood changes, suicidal behavior and suicide in patients who have taken the popular drug also used for allergies. Merck has updated the drug’s labeling four times in the past year to include information on a range of side effects: tremors, anxiousness, depression and suicidal behavior.
  • Merck Says 44,000 Agree to Vioxx Deal

    03/03/2008 9:42:00 AM PST · by BenLurkin · 13 replies · 59+ views
    Associated Press ^ | Monday March 3, 9:03 am ET | Michael Kunzelman,
    NEW ORLEANS (AP) -- The drugmaker Merck says more than 44,000 people have signed up for part of a $4.85 billion settlement over the withdrawn painkiller Vioxx. Merck & Company said Monday those enrollment figures indicate that the settlement is on track to proceed. Merck says that of the roughly 47,000 people who registered for the settlement, more than 44,000 have submitted all or some of the paperwork necessary for enrollment in the deal. People who had enrolled in the settlement by this past Friday are eligible to receive an interim payment later this year. Merck has said it will...
  • HPV Causing More Oral Cancer in Men

    02/03/2008 5:28:03 PM PST · by gondramB · 43 replies · 196+ views
    ATLANTA (AP) — The sexually transmitted virus that causes cervical cancer in women is poised to become one of the leading causes of oral cancer in men, according to a new study. The HPV virus now causes as many cancers of the upper throat as tobacco and alcohol, probably due both to an increase in oral sex and the decline in smoking, researchers say. The only available vaccine against HPV, made by Merck & Co. Inc., is currently given only to girls and young women. But Merck plans this year to ask government permission to offer the shot to boys....
  • Merck recalls 1 million doses of childhood meningitis vaccine

    12/12/2007 2:41:56 PM PST · by Westlander · 11 replies · 343+ views
    New Jersey.com & AP ^ | 12/12/2007, 4:46 p.m. EST | MIKE STOBBE
    ATLANTA (AP) — Merck & Co. is recalling about a million doses of a childhood vaccine, after testing showed a sterilization problem in a Pennsylvania factory.
  • The Vioxx Settlement - A Lesson in Corporate Risk Management

    11/15/2007 11:47:04 AM PST · by Rick Vassar · 3 replies · 162+ views
    The Vioxx Settlement - A Lesson in Corporate Risk Management Written by Rick Vassar Published November 12, 2007 On November 9, 2007, Merck announced that it was settling approximately 27,000 lawsuits arising from the sale and distribution of Vioxx. At the time it was approved by the FDA in May 1999, Vioxx, a Cox-2 inhibitor, was hailed as a breakthrough in pain management. The data that indicated that Vioxx led to an increased chance of heart attack and stroke was evident from the start. As early as April 2000, the FDA expressed concern, and it pressed Merck to add warnings...
  • The HPV Vaccine: Government Mandates and Parental Rights

    11/01/2007 11:02:48 AM PDT · by vadum · 48 replies · 641+ views
    Capital Research Center ^ | November 2007 | Jana Erwin
    Parents believe they have the right to decide what medical treatments are best for their children. But state lawmakers think otherwise because of a disease that has become both a feminist and a public health cause celebre. Across America lawmakers want to compel young girls to be inoculated against human papillomavirus (HPV) years before most become sexually active because there is a chance it can cause cervical cancer. Is replacing parental judgment with mandates by lawmakers and courts good for society?...... Legislators in at least 41 states and the District of Columbia have introduced legislation to require, fund or educate...
  • EIGHT DEATHS LINKED TO LABOUR’S NEW SEX JAB FOR SCHOOLGIRLS (thousands suffer side effects)

    10/29/2007 5:50:52 AM PDT · by NYer · 85 replies · 302+ views
    Daily Express ^ | October 28, 2007
    EIGHT deaths have been linked to the cervical cancer jab which will be given to every 12-year-old girl in Britain under Government plans announced last week. Doctors suspect the jab, which protects against a sexually transmitted human papilloma virus that causes the cancer, may be implicated in 3,461 adverse reactions, including paralysis and seizures. Last week Health Secretary Alan Johnson revealed plans to vaccinate all girls aged between 12 and 13 to cut Britain’s death rate from the disease. He said: “Prevention is better than cure and this vaccine will prevent many women from catching the virus in the first...
  • Business Highlights

    10/22/2007 3:24:27 PM PDT · by BenLurkin · 24+ views
    ap ^ | Monday October 22, 6:10 pm ET
    SAN JOSE, Calif. (AP) -- Apple Inc.'s fiscal fourth-quarter profit jumped 67 percent and easily beat Wall Street expectations, capping a record-breaking year that saw unprecedented momentum in its Mac business, ceaseless consumer interest in its iPod players and a successful introduction of its newest endeavor, the iPhone. For the three months ended Sept. 30, Apple said Monday it earned $904 million, or $1.01 per share, compared with $542 million, or 62 cents per share, in the year-ago quarter. Revenue totaled $6.22 billion, compared with $4.84 billion in the same quarter last year. Analysts surveyed by Thomson Financial were expecting...
  • FDA Approves Merck's New HIV Drug

    10/14/2007 5:36:36 PM PDT · by BenLurkin · 2 replies · 18+ views
    Merck & Co. said Friday the Food and Drug Administration approved its Isentress twice-daily tablets as a treatment for patients who have strains of the HIV virus resistant to multiple antiretroviral drugs. Isentress is the first of a new class of antiretroviral drugs called integrase inhibitors, which work to prevent the virus from inserting its DNA into human DNA, thereby stunting its ability to replicate and infect new cells. Drugs currently on the market inhibit two other enzymes critical to the HIV replication process -- protease and reverse transcriptase -- but Merck says Isentress is the only approved treatment which...
  • Failure of Vaccine Test Is Setback in AIDS Fight

    09/21/2007 11:13:07 PM PDT · by neverdem · 7 replies · 198+ views
    NY Times ^ | September 22, 2007 | LAWRENCE K. ALTMAN and ANDREW POLLACK
    A much-heralded H.I.V. vaccine has failed to work in a large clinical trial, dealing another serious setback to efforts to stop the AIDS epidemic. The vaccine’s developer, Merck, said yesterday that it had halted test vaccinations after the vaccine failed to prevent infection or reduce the severity of infection among volunteers who became infected during the trial. The trial was closely watched because experts considered the vaccine one of most promising to be tested on people so far. This was also the first of a new class of H.I.V. vaccine to get this far in clinical trials. The failure of...
  • Merck's experimental AIDS vaccine fails

    09/21/2007 1:56:21 PM PDT · by Maximus of Texas · 18 replies · 286+ views
    A promising experimental vaccine to prevent the AIDS virus has failed in a crucial experiment, with volunteers becoming infected with HIV anyway, leading the drug developer to halt the study.
  • Deaths Associated with HPV Vaccine Start Rolling In, Over 3500 Adverse Affects Reported

    09/20/2007 4:02:03 PM PDT · by wagglebee · 157 replies · 353+ views
    LifeSiteNews ^ | 9/20/07 | John-Henry Westen
    TORONTO, September 20, 2007 (LifeSiteNews.com) - As Canada, in large part due to aggressive behind the scenes lobbying, rolls out the not-comprehensively-tested Merck HPV vaccine for girls as young as nine, a look at developments on the vaccine south of the border should cause Canadians serious concern.  In the United States a similar lobby campaign by the same company launched the mass HPV vaccination of girls beginning in June last year.  In just little over a year, the HPV vaccine have been associated with at least five deaths, not to mention thousands of reports of adverse effects, hundreds deemed...
  • HPV Vaccine More Effective Than Thought

    09/20/2007 7:44:49 AM PDT · by Alter Kaker · 25 replies · 78+ views
    ABC NEWS ^ | September 20, 2007 | SUSAN KANSAGRA, M.D.
    Merck Study Shows Partial Protection Against Additional Cancer-Causing Strains A study by the company that makes Gardasil, a vaccine that protects against cervical cancer, suggests it may be even more effective than previously thought. The vaccine, manufactured by Merck, had previously been thought to only protect against 70 percent of cervical cancer caused by viruses. However, the new research indicates that it may also have at least some effect against viral strains that cause the other 30 percent. The new data was presented this week by Merck at the Interscience Conference on Antimicrobial Agents and Chemotherapy. The finding was an...
  • New York State and City Sue Merck Over Vioxx

    09/17/2007 10:58:49 PM PDT · by neverdem · 10 replies · 289+ views
    NY Times ^ | September 18, 2007 | SARAH KERSHAW
    Seeking to recoup tens of millions spent by government-financed health programs on prescriptions for Vioxx, New York State and New York City joined yesterday in filing a lawsuit against Merck, the drug’s maker, which withdrew the painkiller from the market in 2004 because of dangerous side effects. The lawsuit, filed yesterday in State Supreme Court in Manhattan, accuses Merck & Company of intentionally concealing the dangers of Vioxx, and therefore defrauding the state Medicaid program, which paid for the prescriptions. The drug was used to treat arthritis and migraines but led to a high risk of heart attacks and strokes....
  • Merck "good" cholesterol drug meets trial goals

    09/03/2007 9:16:12 AM PDT · by BenLurkin · 114+ views
    Reuters ^ | Sunday September 2, 10:20 am ET | Ben Hirschler
    VIENNA (Reuters) - Merck & Co's (NYSE:MRK - News) combination pill to raise "good" HDL cholesterol with less facial flushing -- a common side effect of HDL drugs -- met its main goals in a late-stage test, researchers said on Sunday. Merck believes the favorable results should sway patients, who now shun HDL-boosting drugs because of bothersome flushing, to stick with treatment that may cut their risk of heart attacks and other cardiovascular problems. Analysts reckon that could make Cordaptive, which may get to market in 2008, an eventual multibillion-dollar-a-year seller. But Steven Nissen, a top U.S. cardiologist at the...
  • New risks discovered for HPV (under fingernails)

    08/01/2007 11:01:53 AM PDT · by mngran · 108 replies · 3,222+ views
    Seattle Post-Intelligencer ^ | July 31, 2007 | Tom Paulson
    Controversy continues to plague efforts to protect young women against cervical cancer by vaccinating them against HPV, the human papillomavirus, but one leading scientist's discovery could throw a monkey wrench into the debate. "We found HPV under the fingernails of young men," said Dr. Laura Koutsky, a University of Washington epidemiologist. Koutsky led some of the pioneering research and clinical trials that resulted in an HPV vaccine, Merck's Gardasil, recently approved for use in girls and young women. The reason her fingernail finding is a potential bombshell has to do with why the vaccine is controversial. HPV, which is the...
  • Ontario Says HPV Vaccination Program to Wait on Medical Report

    07/25/2007 4:25:54 AM PDT · by monomaniac · 2 replies · 464+ views
    Ontario Says HPV Vaccination Program to Wait on Medical Report By Hilary White TORONTO, July 24, 2007 (LifeSiteNews.com) - The Ontario government has told the Toronto Board Of Health that plans to vaccinate all Ontario women and girls between the ages of 9 and 26 for HPV will have to wait on a report from medical experts later this year. In February this year, the federal government announced its plan to vaccinate women and girls across the country and has pledged $300 million for the project. The vaccination of children as young as nine was recommended by the National Advisory...
  • Amendment Keeps Taxpayers from Funding Mandatory HPV Vaccines

    07/22/2007 11:12:08 AM PDT · by monomaniac · 41 replies · 879+ views
    CitizenLink.com ^ | 7-19-2007
    Amendment Keeps Taxpayers from Funding Mandatory HPV Vaccines The U.S. House passed an amendment Wednesday that will keep the government from funding mandatory vaccination against the human papillomavirus (HPV).Republican Reps. Phil Gingrey of Georgia and Jim Jordan of Ohio introduced the amendment following efforts across the country to require young girls to receive the vaccine to attend school. Merck & Co.’s Gardasil vaccine protects against the four most common strains of HPV, a sexually transmitted infection. Focus on the Family Action supports widespread availability of the vaccine, but holds that parents should make the decision of whether their daughters are...
  • None dare call it a conspiracy [Gardasil, Planned Parenthood]

    06/24/2007 9:53:31 AM PDT · by Quiet Man Jr. · 8 replies · 1,120+ views
    Celebrate Life ^ | May-June 2007 | Jim Sedlak
    Just because you’re paranoid doesn’t mean that no one is out to get you. With these words, I will relate a story about what is going on in the United States regarding those who wish to control the lives of our young people and the future generations of our nation... In 1985, Planned Parenthood people were among the participants in an exercise that produced a document called Inventing the Future: Alternatives to Adolescent Pregnancy. The document was the result of creative thinking on the part of the participants on how they would want things to operate in the future. It...
  • Gardasil has booth in WalMart

    06/23/2007 11:27:29 AM PDT · by DJ MacWoW · 295 replies · 5,329+ views
    Self | June 23, 2007 | DJMacWoW
    Hubby went to WalMart in Pennsylvania today. At the main entrance is a Gardasil booth handing out pamphlets. There was a line of parents so Hubby started a rant. He asked the woman why not just teach your daughters to keep their knickers on? Her answer was because they won't. Hubby responded that our daughter is in her 20's and still a virgin. She responded that daughters lie. He offered to let our "female tiger" talk to her. At that point the woman asked if he was on his cellphone. He said "Yes" And how about this not being tested...